Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Robotic Ankle Assist Device · 1 trial · 1 indication
How fast someone prefers to walk
| Arm | Type | Description |
|---|---|---|
| Therapist supervised assistance training | EXPERIMENTAL | Assistance training with the RAAD under therapist supervision. |
| Therapist supervised resistance training | EXPERIMENTAL | Resistance training with the RAAD under therapist supervision. |
| Name | Type | Description |
|---|---|---|
| Robotic Ankle Assist Device (RAAD) | DEVICE | The RAAD (Robotic Ankle Assist Device) is an intelligent, powered ankle device designed to increase independence, mobility, and deliver gait training to children with movement disorders, such as CP |
Inclusion Criteria: Diagnosis of cerebral palsy. Any sex, race, ethnicity or socioeconomic status. GMFCS level I, II, or II. Ability to walk for at least 6 minutes (assisted or unassisted). Age between 8-18 years. Height/weight/BMI between the 5th - 95th percentile of children with CP. Able to und...
Robotic Ankle Assist Device is an investigational device being developed for use in Cerebral Palsy. It is currently in Phase 1 clinical development. The device is intended to assist ankle function in patients with this condition, though specific efficacy outcomes have not been reported.
Robotic Ankle Assist Device is being developed by National Healthcare Corp. (ticker: NHC). The company is conducting clinical research on this device for the treatment of Cerebral Palsy.
Robotic Ankle Assist Device is in Phase 1 clinical development. It is an investigational device and has not been approved by regulatory authorities. One Phase 1 trial has been completed.
Robotic Ankle Assist Device has one completed clinical trial, NCT04516343, titled 'Development of a Robotic Ankle Assist Device'. This Phase 1 study enrolled 31 participants with Cerebral Palsy in the United States, with a minimum age of 8 years.
No alternative names for Robotic Ankle Assist Device have been reported. It is identified by this name in clinical trial records and by its developer, National Healthcare Corp.